Nomura Holdings Inc Gilead Sciences, Inc. Call Options Transaction History

Nomura Holdings Inc

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $395,658 - $448,686	5,400 Added 23.79%	28,100 $2.28 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $1.68 Million - $1.83 Million	22,700 New	22,700 $1.7 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $59.5 Million - $85.4 Million	954,900 New	954,900 $79.9 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $39.8 Million - $44.9 Million	690,000 Added 6900.0%	700,000 $45.4 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $11.9 Million - $15.2 Million	-190,000 Reduced 95.0%	10,000 $742,000
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $9.14 Million - $10.2 Million	146,200 Added 271.75%	200,000 $13.2 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $441,942 - $576,700	-7,300 Reduced 11.95%	53,800 $3.39 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $1.55 Million - $1.81 Million	-23,900 Reduced 28.12%	61,100 $3.01 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $8.7 Million - $10.6 Million	-119,500 Reduced 58.44%	85,000 $6.46 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $6.19 Million - $7.55 Million	85,000 Added 71.13%	204,500 $15.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $8.62 Million - $10.2 Million	119,500	119,500 $9.72 Million

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.